World News
-
Recursion Pharmaceuticals secures $121M in Series C funding
World | News | 0 Comment | 16 Jul, 2019
Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discover and develop drugs at scale has announced the closing of a $121 mil...Read more
-
Illumina expands Genomics Accelerator to Cambridge, UK
World | News | 0 Comment | 16 Jul, 2019
Illumina has announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creat...Read more
-
Gilead Sciences, Renown Institute for Health Innovation collaborate for NASH
World | News | 0 Comment | 16 Jul, 2019
Gilead Sciences and the Renown Institute for Health Innovation (IHI) have announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance...Read more
-
J&J announces PPP for Investigational Prophylactic HIV Vaccine
World | News | 0 Comment | 16 Jul, 2019
Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Companies, together with a consortium of global partners are preparing to ...Read more
-
Michigan scientists develop EpiPen to heal spinal cord injuries
World | News | 0 Comment | 16 Jul, 2019
An injection of nanoparticles can prevent the body’s immune system from overreacting to trauma, potentially preventing some spinal cord injuries from resulting in paralysis. The appr...Read more
-
Abbott gets FDA approval for Alinity™ s System
World | News | 0 Comment | 15 Jul, 2019
Abbott has announced that U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new solution will bring the latest scre...Read more
-
Gilead Sciences, Galapagos enter into deal worth $5B
World | News | 0 Comment | 15 Jul, 2019
US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year global research and development collaboration. Through this agreement...Read more
-
Certara forms new practice area to achieve health equity
World | News | 0 Comment | 15 Jul, 2019
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, has announced that it has formed a new practice area ...Read more
-
SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101
World | News | 0 Comment | 12 Jul, 2019
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15. The pha...Read more
-
Celsius and J&J sign R&D collaboration agreement
World | News | 0 Comment | 10 Jul, 2019
Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with autoimmune diseases and cancer has announced a collaboration with Jansse...Read more
-
Sandoz launches oncology generic gefitinib in 13 EU countries
World | News | 0 Comment | 10 Jul, 2019
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating mutati...Read more
-
DTC genetic testing market size to exceed $2.5bn by 2025
World | Analysis | 0 Comment | 10 Jul, 2019
Increasing prevalence of rare genetic disorders globally coupled with extensive applications of direct-to-consumer genetic testing in early detection of cancer and other genetic disorder wi...Read more
-
WHO updates global guidance on medicines
World | News | 0 Comment | 10 Jul, 2019
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available an...Read more
-
World | News | 0 Comment | 09 Jul, 2019
Lyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership with Gilead Sciences, Inc. to develop and commercialize ultra-long-acting oral HIV thera...Read more
-
ImaginAb teams up with Roche for multiple cancer clinical trials
World | News | 0 Comment | 10 Jul, 2019
ImaginAb Inc., a US based clinical stage immuno-oncology imaging company has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreement, R...Read more
-
mHealth Market will register 38.0% CAGR Growth to cross $289.4 Bn by 2025
World | Opinion | 0 Comment | 09 Jul, 2019
Growing prevalence of chronic diseases such as high blood pressure, diabetes and cardiac diseases will drive mHealth market growth in the coming years. mHealth technology is viewed as a sol...Read more
-
Logmore: Temperature Monitoring of Online Pharmacy Shipments Ensuring Medicine Safety
World | News | 0 Comment | 09 Jul, 2019
Logmore is a Finnish start-up company with the first solution in the world to suit end-to-end monitoring. The company’s mission is to minimize waste and spoilage on a global scale by ...Read more
-
Improved website for My Cancer Genome launched
World | News | 0 Comment | 09 Jul, 2019
Vanderbilt-Ingram Cancer Center and GenomOncology LLC announce the launch of the newly redesigned and improved My Cancer Genome website. The new site showcases the breadth and depth of cura...Read more
